Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
988
-0.36%
|
$607,620
$615.59 P/Share
|
|
Jun 11
2020
|
Huda Y Zoghbi Director |
SELL
Open market or private sale
|
Direct |
1,706
-72.63%
|
$1,066,250
$625.0 P/Share
|
|
Jun 11
2020
|
Huda Y Zoghbi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,706
+42.07%
|
$667,046
$391.92 P/Share
|
|
Jun 10
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,512
-9.01%
|
$1,532,320
$610.18 P/Share
|
|
Jun 10
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+11.16%
|
$952,000
$272.7 P/Share
|
|
Jun 10
2020
|
Huda Y Zoghbi Director |
SELL
Open market or private sale
|
Direct |
1,706
-11.95%
|
$1,042,366
$611.13 P/Share
|
|
Jun 10
2020
|
Huda Y Zoghbi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,706
+42.07%
|
$667,046
$391.92 P/Share
|
|
Jun 09
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
4,271
-1.77%
|
$2,588,226
$606.43 P/Share
|
|
Jun 09
2020
|
Sanofi |
SELL
Open market or private sale
|
Indirect |
120,234
-30.06%
|
$71,779,698
$597.48 P/Share
|
|
Jun 08
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,229
-6.48%
|
$6,647,568
$592.42 P/Share
|
|
Jun 08
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,500
+8.15%
|
$4,216,000
$272.7 P/Share
|
|
Jun 08
2020
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
10,838
-5.08%
|
$6,426,934
$593.33 P/Share
|
|
Jun 08
2020
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,838
+21.53%
|
$4,476,094
$413.33 P/Share
|
|
Jun 05
2020
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
2,559
-79.92%
|
$1,535,400
$600.0 P/Share
|
|
Jun 05
2020
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,559
+44.42%
|
$1,000,569
$391.92 P/Share
|
|
Jun 01
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$60,200
$603.0 P/Share
|
|
May 29
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Indirect |
1,000
-11.67%
|
$596,000
$596.51 P/Share
|
|
May 29
2020
|
Sanofi |
SELL
Open market or private sale
|
Indirect |
2,399,552
-85.71%
|
$1,221,371,968
$509.85 P/Share
|
|
May 29
2020
|
Sanofi |
SELL
Open market or private sale
|
Direct |
20,421,899
-100.0%
|
$10,394,746,591
$509.85 P/Share
|
|
May 28
2020
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
1,000
-13.08%
|
$578,000
$578.94 P/Share
|
|
May 28
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Indirect |
1,000
-10.23%
|
$579,000
$579.0 P/Share
|
|
May 27
2020
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Direct |
73,100
-23.75%
|
-
|
|
May 21
2020
|
P Roy Vagelos Director |
SELL
Open market or private sale
|
Direct |
149,594
-1.7%
|
$84,819,798
$567.49 P/Share
|
|
May 20
2020
|
P Roy Vagelos Director |
SELL
Payment of exercise price or tax liability
|
Direct |
159,642
-9.13%
|
$90,995,940
$570.97 P/Share
|
|
May 20
2020
|
P Roy Vagelos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
312,500
+12.22%
|
$9,375,000
$30.63 P/Share
|
|
May 15
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
8,380
-36.73%
|
$4,793,360
$572.0 P/Share
|
|
May 14
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
9,931
-30.32%
|
$5,690,463
$573.18 P/Share
|
|
May 14
2020
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
18,311
+35.86%
|
$1,080,349
$59.2 P/Share
|
|
May 13
2020
|
Michael S Brown Director |
SELL
Bona fide gift
|
Indirect |
1,000
-8.81%
|
-
|
|
May 13
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
5,000
-4.15%
|
$2,900,000
$580.0 P/Share
|
|
May 13
2020
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.99%
|
$165,000
$33.42 P/Share
|
|
May 12
2020
|
Leonard S Schleifer President & CEO |
SELL
Open market or private sale
|
Direct |
150,922
-1.3%
|
$85,572,774
$567.49 P/Share
|
|
May 11
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Indirect |
850
-7.29%
|
$488,750
$575.0 P/Share
|
|
May 11
2020
|
Leonard S Schleifer President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
161,578
-12.1%
|
$92,261,038
$571.43 P/Share
|
|
May 11
2020
|
Leonard S Schleifer President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
312,500
+18.93%
|
$9,375,000
$30.63 P/Share
|
|
May 11
2020
|
Neil Stahl EVP Research and Development |
SELL
Open market or private sale
|
Direct |
5,305
-8.94%
|
$3,013,240
$568.97 P/Share
|
|
May 08
2020
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
7,195
-30.13%
|
$4,029,200
$560.67 P/Share
|
|
May 08
2020
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+34.36%
|
$650,000
$52.03 P/Share
|
|
May 07
2020
|
Huda Y Zoghbi Director |
SELL
Open market or private sale
|
Direct |
5,118
-33.3%
|
$2,901,906
$567.43 P/Share
|
|
May 07
2020
|
Huda Y Zoghbi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,118
+47.04%
|
$2,001,138
$391.92 P/Share
|
|
May 07
2020
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Open market or private sale
|
Direct |
39,583
-5.94%
|
$22,285,229
$563.01 P/Share
|
|
May 07
2020
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
1,809
-73.78%
|
$1,016,658
$562.0 P/Share
|
|
May 06
2020
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
15,000
-30.68%
|
$8,460,000
$564.38 P/Share
|
|
May 06
2020
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+47.13%
|
$2,655,000
$177.82 P/Share
|
|
May 06
2020
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Payment of exercise price or tax liability
|
Direct |
45,996
-29.18%
|
$25,527,780
$555.77 P/Share
|
|
May 06
2020
|
Daniel P Van Plew EVP & General Mgr Industrial O |
BUY
Exercise of conversion of derivative security
|
Direct |
85,579
+35.19%
|
$4,450,108
$52.03 P/Share
|
|
May 06
2020
|
Michael S Brown Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,661
-32.56%
|
$2,031,855
$555.77 P/Share
|
|
May 06
2020
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,470
+27.97%
|
$1,777,750
$325.18 P/Share
|
|
May 06
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
50,124
-5.62%
|
$27,518,076
$549.34 P/Share
|
|
May 06
2020
|
Arthur F Ryan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,124
+11.66%
|
$17,994,516
$359.12 P/Share
|